Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
about
CRF receptor antagonist astressin-B reverses and prevents alopecia in CRF over-expressing miceCorticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas.Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infectionUrocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptorsCorticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanismThe hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptorsControl of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptorHuman trophoblast function during the implantation processGenetic alteration of anxiety and stress-like behavior in mice lacking CaMKIVEvidence for the role of corticotropin-releasing factor in major depressive disorderInflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).Role of kappa-opioid receptors in stress and anxiety-related behavior.The cochlea as an independent neuroendocrine organ: expression and possible roles of a local hypothalamic-pituitary-adrenal axis-equivalent signaling systemUrocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior.Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligandNMR Structure of the First Extracellular Domain of Corticotropin-releasing Factor Receptor 1 (ECD1-CRF-R1) Complexed with a High Affinity AgonistGenetic Approaches to Hypothalamic-Pituitary-Adrenal Axis RegulationCrh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndromeUrocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle responseA role for LYNX2 in anxiety-related behavior.Amygdala protein kinase C epsilon regulates corticotropin-releasing factor and anxiety-like behaviorTopographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylaseA single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonistsCRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent mannerCRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behaviorCircadian rise in maternal glucocorticoid prevents pulmonary dysplasia in fetal mice with adrenal insufficiencySociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in miceStress and the brain: from adaptation to diseaseThe long-term impact of early life pain on adult responses to anxiety and stress: Historical perspectives and empirical evidence.Sex differences in NMDA GluN1 plasticity in rostral ventrolateral medulla neurons containing corticotropin-releasing factor type 1 receptor following slow-pressor angiotensin II hypertension.Exercise offers anxiolytic potential: a role for stress and brain noradrenergic-galaninergic mechanisms.Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats.Posttraumatic stress disorder-like induction elevates β-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses.Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult miceA transcriptome-wide screen for mRNAs enriched in fetal Leydig cells: CRHR1 agonism stimulates rat and mouse fetal testis steroidogenesis.Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in ratsFemale Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies.Inhibition of corticotropin releasing factor expression in the central nucleus of the amygdala attenuates stress-induced behavioral and endocrine responses.Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behaviorAPP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).
P2860
Q21091067-C6A5B6E3-D545-4F45-B9AE-A77E075A774DQ24523847-54D5C60E-D5D7-44EB-8B1C-7136765C2F7FQ24531350-307A46E7-8D85-4D65-BD85-34364FFBE7FCQ24595282-382E4583-4262-4556-A82E-7852C54C8226Q24645551-6BACA4B4-63E2-4BD9-A3F8-6955FC4E00F6Q24676277-4933CC83-C170-4470-90CA-788A60D39F18Q24683260-799EF7F2-6E7F-43A8-AA65-86DE5F234FD6Q24811501-468FEB27-6D17-4AE6-BDCE-1D5142018B43Q24814072-54E29B07-158D-4592-8982-ABF8210CC48CQ26798878-E80D096E-4D1A-4C3F-A8BB-171CBCA51E60Q26830867-07F821F5-5218-4312-9C1C-BB2C9A4C8C7DQ26991739-14F75AA6-FD81-4F36-805E-8AED750CB621Q26996598-FF0A1928-EEB8-4E9D-BE11-2C70A734F8C9Q27011274-E44A68F5-F1F8-483A-BC7A-35A4C3A9069DQ27644056-AD417ED0-37C4-4719-AFE3-CCFE73530AF3Q27664491-6E39F94D-644A-4D77-AF9F-09AAC7B95FC6Q28082581-FDF930FC-A462-49F1-8C66-C397A4A20A3CQ28257072-9909C4AD-5E49-4D4C-9A53-A77063183356Q28507210-424380F3-FC6E-4F5A-B6E9-EDC63890721FQ28507664-30027D2D-FB18-480C-8B62-DE16EF7F1389Q28510780-AA95E0D2-6ED9-4557-B2F6-ADD20812A667Q28569531-5679BE08-4B9B-48FC-AAAF-C5192C5579D8Q28572089-0998B429-DA31-4D6A-85FE-B04C921AEBA5Q28576915-503C0DA5-F17D-4DC0-B071-A70A1CCD11A7Q28580222-47092241-0DE4-4A4B-8131-B48728E73C7EQ28594428-130BD868-99FD-4CBA-96AF-74647A1D1ED6Q29618044-DECD893D-3672-4A72-A422-B8466EBD68E4Q29619381-9C7EAE7D-6A8D-4ED1-89E5-574379345FCFQ30366741-9D043339-8ED5-48A9-8EC7-255C570C304BQ30371466-0A04B956-EE94-4388-A863-306D10CF0973Q30387419-2A9401E9-C73B-4426-8B08-971A84CBEF38Q30389951-C32B625F-9E03-4357-BB17-E79EA5FF09DEQ30405044-E66AA106-6EA3-405F-8E61-3B4F82C5E41BQ30413232-7314B53F-D9E4-4A9F-9F35-A5C6D7FEFE40Q30424106-3C3869F5-598A-44FC-98C3-65782BD5C95BQ30431860-DD80EACD-7475-4319-A7BC-544AC630435DQ30445073-D562D38C-7666-4E4F-9B07-2080E9D6F282Q30447564-30AF65B8-8BA4-4E2B-8FBC-33EA6E4C1269Q30448992-98391151-8FB4-41E2-9C77-11FBF282F1D5Q30455082-35BF28F6-F155-464F-9491-9F003A862F62
P2860
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
description
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1998
@ast
im Juni 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1998/06/01)
@sk
vědecký článek publikovaný v roce 1998
@cs
wetenschappelijk artikel (gepubliceerd op 1998/06/01)
@nl
наукова стаття, опублікована в червні 1998
@uk
научни чланак (објављен 1998/06/01)
@sr
name
Corticotropin releasing factor ...... ant neuroendocrine development
@ast
Corticotropin releasing factor ...... ant neuroendocrine development
@en
Corticotropin releasing factor ...... ant neuroendocrine development
@nl
type
label
Corticotropin releasing factor ...... ant neuroendocrine development
@ast
Corticotropin releasing factor ...... ant neuroendocrine development
@en
Corticotropin releasing factor ...... ant neuroendocrine development
@nl
prefLabel
Corticotropin releasing factor ...... ant neuroendocrine development
@ast
Corticotropin releasing factor ...... ant neuroendocrine development
@en
Corticotropin releasing factor ...... ant neuroendocrine development
@nl
P2093
P3181
P1433
P1476
Corticotropin releasing factor ...... ant neuroendocrine development
@en
P2093
A. Contarino
C. A. Bentley
G. F. Koob
G. W. Smith
J. M. Aubry
L. H. Gold
L. M. Bilezikjian
P304
P3181
P356
10.1016/S0896-6273(00)80491-2
P407
P577
1998-06-01T00:00:00Z